Clinical Trial Update: Prospective Exploratory Study to Describe Hepatitis B Virus (HBV) Kinetics During Treatment With Telbivudine [Phase 3]

View source ↗

Summary

This clinical trial update describes a Phase 3 exploratory study of hepatitis B virus kinetics during telbivudine treatment. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Telbivudine (telbivudine)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Hepatitis B, Chronic | Phase 3 | Status: COMPLETED